The requirements of a specialist breast centre
2020 · The Breast · 192 citations
https://doi.org/10.1016/j.breast.2020.02.003
B
Berta Sousa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.1K
Citations
16
h-index
23
i10-index
Berta Sousa is an academic researcher from Champalimaud Foundation. The author has contributed to research in topics: Cancer survivorship and care & Breast Cancer Treatment Studies & Family Support in Illness. The author has an h-index of 16, co-authored 81 publications.
ORCID: 0000-0003-2287-4799Papers by this author
worksLong term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression
2022 · The Breast · 17 citations
https://doi.org/10.1016/j.breast.2022.05.004
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial
2022 · Journal of Geriatric Oncology · 10 citations
https://doi.org/10.1016/j.jgo.2022.01.009
Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers
2012 · Annals of Oncology · 9 citations
https://doi.org/10.1093/annonc/mds348
Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
2022 · Brain Behavior & Immunity - Health · 5 citations
https://doi.org/10.1016/j.bbih.2022.100433
Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2– advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, −3, and −7 trials
2025 · European Journal of Cancer · 4 citations
https://doi.org/10.1016/j.ejca.2025.115225
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat